Concord Asset Management (Virginia)’s Amgen AMGN Stock Holding History

Concord Asset Management (Virginia)’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.24M	Buy	8,937 +195	+2%	+$66.8K	0.5%	50
2026 Q1	$3.08M	Sell	8,742 -370	-4%	-$132K	0.52%	51
2025 Q4	$2.98M	Sell	9,112 -21	-0.2%	-$6.66K	0.52%	48
2025 Q3	$2.58M	Sell	9,133 -334	-4%	-$96.9K	0.47%	54
2025 Q2	$2.64M	Buy	9,467 +705	+8%	+$200K	0.4%	62
2025 Q1	$2.43M	Buy	8,762 +526	+6%	+$155K	0.54%	49
2024 Q4	$2.15M	Buy	8,236 +182	+2%	+$54K	0.47%	55
2024 Q3	$2.59M	Buy	8,054 +786	+11%	+$257K	0.59%	46
2024 Q2	$2.27M	Buy	7,268 +759	+12%	+$223K	0.56%	46
2024 Q1	$1.85M	Buy	6,509 +771	+13%	+$226K	0.49%	50
2023 Q4	$1.65M	Buy	5,738 +2,818	+97%	+$768K	0.49%	46
2023 Q3	$785K	Buy	2,920 +738	+34%	+$184K	0.26%	63
2023 Q2	$485K	Buy	2,182 +577	+36%	+$134K	0.17%	72
2023 Q1	$388K	Buy	1,605 +734	+84%	+$180K	0.16%	69
2022 Q4	$229K	Buy	+871	New	+$233K	0.15%	55

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Concord Asset Management (Virginia)'s AMGN Position: Q2 2026 in Review

Concord Asset Management (Virginia) increased its Amgen (AMGN) stake by 2.2% in Q2 2026, buying an estimated $66.8K and bringing the position to 8,937 shares worth $3.24M. The position accounts for 0.5% of the portfolio, ranked #50.

Concord Asset Management (Virginia) first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Concord Asset Management (Virginia) held 8,937 shares of Amgen worth $3.24M as of Q2 2026.
Concord Asset Management (Virginia) bought 195 Amgen shares in Q2 2026, an estimated $66.8K.
Amgen made up 0.5% of Concord Asset Management (Virginia)'s portfolio in Q2 2026, its #50 holding.
Concord Asset Management (Virginia) first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Concord Asset Management (Virginia)'s 13F filing for Q2 2026, filed 27 Jul 2026.